The prevalence of medulloblastoma in GS is significantly higher in patients with the SUFU gene mutation (33%) than in patients with the patched 1 (PTCH1) gene mutation (<2%) [10,11,13]. The gene discussed is SUFU; the disease is medulloblastoma.